Andere Sprachen Nahdi Medical Company

Aktien

A3DH4U

SA15HG521213

4164

Handel - Medikamente

Markt geschlossen - Saudi Arabian S.E. 14:20:00 14.07.2026 % 5 Tage Veränd. 1. Jan.
91,35 SAR -0,81 % Intraday Chart für Nahdi Medical Company -2,97 % -3,84 %

Andere Sprachen

21.05. United Securities Tweaks Nahdi Medical Co Price Target, Profit Forecast After Q1 Earnings
14.05. Riyad Capital Revises Rating, Price Target on Nahdi Medical After Q1 Earnings
07.05. Nahdi Medical Company Reports Earnings Results for the First Quarter Ended March 31, 2026
06.05. Al Nahdi Medical Q1 profit SAR 235.7 million
06.05. Nahdi Medical Logs Lower Q1 Profit; Revenue Up
04.05. Nahdi Medical Partners with Six Charitable Organizations for Healthcare Services Initiative
31.03. United Securities Cuts Nahdi Medical Target Price Amid Increasing Geopolitical Risks
16.03. Nahdi Medical Company Reports Earnings Results for the Full Year Ended December 31, 2025
09.03. Tadawul All Share Index Tumbles as Triple-Digit Oil Weighs
09.03. Nahdi Medical's FY25 Net Profit, Revenue Rise
09.03. Nahdi Medical Company Announces Cash Dividend Distribution for the Second Half of 2025, Payable on April 09, 2026
13.02. Nahdi Medical Dispenses Dose of Growth
30.10.25 Nahdi Medical Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
29.10.25 Al Nahdi Medical Q3 profit SAR 161.2 million
29.10.25 Nahdi Medical's Q3 Net Profit Falls; Revenue Up
10.10.25 Nahdi Medical Launches New Prescription Service in Saudi Arabia
30.09.25 Nahdi Medical to Launch Prescription Dispensing Services
30.09.25 Nahdi Medical Company Announces Launch of "Wasfaty" Prescription Dispensing Services in Collaboration with the National Unified Procurement Company
18.08.25 MIDEAST STOCKS-Gulf shares mixed on Fed rate cut uncertainty
13.08.25 MIDEAST STOCKS-Gulf bourses mixed on weaker corporate earnings, Fed rate cut hopes
02.08.25 Nahdi Medical Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
30.07.25 MIDEAST STOCKS-Major Gulf markets ease as earnings underwhelm
30.07.25 Nahdi Medical H1 dividend per share SAR 2.60
30.07.25 Al Nahdi Medical Q2 net profit SAR 238.4 million
30.07.25 Nahdi Medical's H1 Net Profit, Revenue Climb
Keine Ergebnisse zu dieser Suche